Literature DB >> 4858086

Fusaric acid in Parkinson's disease.

T N Chase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4858086     DOI： 10.1212/wnl.24.7.637

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Biochemical mechanisms and management of choreiform movement disorders.

Authors:  L de Silva
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 2.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

3.  Serum dopamine-beta-hydroxylase in parkinsonism.

Authors:  E S Markianos; E Rüther
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 4.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Concise Total Synthesis and Antifungal Activities of Fusaric Acid, a Natural Product.

Authors:  Bin Bin Huang; Ya Yi Liu; Peng Fei Zhu; Yi Cheng Jiang; Ming-An Ouyang
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.